De The H - Search Results

1

Evidence of chromosome regions and gene involvement in inflammatory breast cancer.

Lerebours F, Bertheau P, Bieche I, Driouch K, De The H, Hacene K, Espie M, Marty M, Lidereau R. Lerebours F, et al. Among authors: de the h. Int J Cancer. 2002 Dec 20;102(6):618-22. doi: 10.1002/ijc.10729. Int J Cancer. 2002. PMID: 12448004

2

[Tissue microdissection: application to the study of cancer of the breast].

Bertheau P, de Thé H, de Roquancourt A, Lerebours F, Espié M, Janin A. Bertheau P, et al. Among authors: de the h, de roquancourt a. Ann Pathol. 1999;19(5 Suppl):S3-6. Ann Pathol. 1999. PMID: 10599450 French. No abstract available.

3

Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers.

Turpin E, Dalle B, de Roquancourt A, Plassa LF, Marty M, Janin A, Beuzard Y, de Thé H. Turpin E, et al. Among authors: de the h, de roquancourt a. Oncogene. 1999 Dec 16;18(54):7834-7. doi: 10.1038/sj.onc.1203196. Oncogene. 1999. PMID: 10618725

4

Microdissection and breast cancer.

Bertheau P, Rivet J, de Roquancourt A, de Thé H, Espié M, Janin A. Bertheau P, et al. Among authors: de the h, de roquancourt a. J Mol Med (Berl). 2000;78(7):B31. J Mol Med (Berl). 2000. PMID: 11043391 No abstract available.

5

Allelic loss detection in inflammatory breast cancer: improvement with laser microdissection.

Bertheau P, Plassa LF, Lerebours F, de Roquancourt A, Turpin E, Lidereau R, de Thé H, Janin A. Bertheau P, et al. Among authors: de the h, de roquancourt a. Lab Invest. 2001 Oct;81(10):1397-402. doi: 10.1038/labinvest.3780353. Lab Invest. 2001. PMID: 11598152 Free article.

6

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy.

Bertheau P, Plassa F, Espié M, Turpin E, de Roquancourt A, Marty M, Lerebours F, Beuzard Y, Janin A, de Thé H. Bertheau P, et al. Among authors: de the h, de roquancourt a. Lancet. 2002 Sep 14;360(9336):852-4. doi: 10.1016/S0140-6736(02)09969-5. Lancet. 2002. PMID: 12243922

7

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.

Bertheau P, Turpin E, Rickman DS, Espié M, de Reyniès A, Feugeas JP, Plassa LF, Soliman H, Varna M, de Roquancourt A, Lehmann-Che J, Beuzard Y, Marty M, Misset JL, Janin A, de Thé H. Bertheau P, et al. Among authors: de the h, de reynies a, de roquancourt a. PLoS Med. 2007 Mar;4(3):e90. doi: 10.1371/journal.pmed.0040090. PLoS Med. 2007. PMID: 17388661 Free PMC article.

8

Changes in allelic imbalances in locally advanced breast cancers after chemotherapy.

Varna M, Soliman H, Feugeas JP, Turpin E, Chapelin D, Legrès L, Plassa LF, de Roquancourt A, Espié M, Misset JL, Janin A, de Thé H, Bertheau P. Varna M, et al. Among authors: de the h, de roquancourt a. Br J Cancer. 2007 Oct 22;97(8):1157-64. doi: 10.1038/sj.bjc.6603937. Epub 2007 Sep 18. Br J Cancer. 2007. PMID: 17876337 Free PMC article.

9

[Exquisite sensitivity of TP53 mutant breast cancers to dose-dense chemotherapy].

Lehmann-Che J, Turpin E, Bertheau P, Espié M, de Thé H. Lehmann-Che J, et al. Among authors: de the h. Med Sci (Paris). 2007 Nov;23(11):1021-3. doi: 10.1051/medsci/200723111021. Med Sci (Paris). 2007. PMID: 18021719 Free article. French. No abstract available.

10

TP53 status and response to chemotherapy in breast cancer.

Bertheau P, Espié M, Turpin E, Lehmann J, Plassa LF, Varna M, Janin A, de Thé H. Bertheau P, et al. Among authors: de the h. Pathobiology. 2008;75(2):132-9. doi: 10.1159/000123851. Epub 2008 Jun 10. Pathobiology. 2008. PMID: 18544968 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters